Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENOCHARCOT trial
2024-515365-34-00Phase 4Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Nov 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Charcot neuroarthropathy (CN) comparing Denosumab arm with Placebo arm (2 arms). Primary endpoint: Time to clinical healing/remission. Planned start Nov 2020; status: authorised.
02
Drugs
denosumab
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on 2024-515365-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515365-34-00.